Interius BioTherapeutics

Website

Developer of a genetic medicines precision delivery platform intended to treat hematologic malignancies. The company's platform develops chimeric antigen receptor T cells directly in vivo, bypassing t...

Healthcare
Philadelphia, PA, United States
Founded 2019
52 employees
Website
Valuation
$350M
Market implied
Share Price
N/A
Total Raised
$169.6M
Last Round
N/A
Investors
+19 other investors
View all 19 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Interius BioTherapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required